Moderna 's ( MRNA 3.13%) wild success in the COVID-19 vaccine market has worn off. The company's revenue, earnings, and stock ...

Researchers developing Australia’s first mRNA Covid vaccine say they may have solved the “immune imprinting” issue that has ...

Despite being a pioneer in developing one of the first and most widely used COVID-19 vaccines, shares of Moderna MRNA have ...

Moderna has struggled in the post-COVID era, making its capacity to generate free cash flows doubtful. See why MRNA stock is ...

Stancik, 24, said she was "abandoned by the military" after suffering three heart attacks and a stroke after receiving the ...

The vaccine maker previously revealed plans to slash R&D budget to conserve cash for product launches, but after a rough year ...

All new Pfizer and Moderna vaccines target the Omicron variant KP.2 strain of SARS-CoV-2, the virus that causes COVID. Spikevax, the COVID-19 vaccine manufactured by Moderna and FDA-approved for ...

The first time I got a Novavax Covid vaccine, it felt almost subversive. Over the previous few years, every mRNA-based booster I’d gotten — the ones made by Moderna and Pfizer — had felt ...

A third dose of COVID-19 vaccine is beneficial among older Medicare beneficiaries, regardless of prior medically attended COVID-19 diagnoses.

Argus downgraded Moderna (MRNA) to Hold from Buy without a price target The firm sees limited upside for the stock over the next 12 months as ...

A person with COVID-19 could be contagious for a longer period of time than if they had the flu, according to the CDC website ...

Both candidates combine 2 already licensed vaccines to prevent influenza and COVID-19. Fast Track designation was granted ...